
Cutting-edge DNA mapping technology has identified new genetic information that can help researchers decipher more genetic diseases, a new study finds. The research was presented at the Pediatric Academic Societies (PAS) 2025 Meeting, held April 24–28 in Honolulu.
The technology identified more genomic imprinting in DNA—10 times as much—than previously published data. Genomic imprinting occurs when only one parent’s gene is expressed in a child’s genetic makeup, which contributes to rare pediatric diseases, according to researchers.
Study authors said the technology, known as HiFi long-read sequencing, helps identify patterns in DNA that could show which parent is linked to genomic imprinting.
“Genomic research is uniquely powerful and new technologies continue to enhance understanding of rare diseases,” said Elin Grundberg, Ph.D., Genomic Medicine Center, Children’s Mercy Kansas City and presenting author. “The novel HiFi long-read sequencing technology helps researchers uncover insights into human development and potentially identify diseases that have eluded science.”
Researchers applied the technology to more than 200 genetic samples from cells of nearly 70 six-to-eight-week-old placentas at Children’s Mercy Kansas City.
More information:
Abstract: Mapping parent of origin methylation by long-read sequencing reveals novel imprinting and insight into pediatric disease.
Citation:
New DNA-reading technology holds promise for rare disease research (2025, April 25)
retrieved 25 April 2025
from https://medicalxpress.com/news/2025-04-dna-technology-rare-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.